1. Home
  2. FIGS vs ZLAB Comparison

FIGS vs ZLAB Comparison

Compare FIGS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FIGS Inc.

FIGS

FIGS Inc.

HOLD

Current Price

$12.41

Market Cap

2.4B

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.52

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIGS
ZLAB
Founded
2013
2013
Country
United States
China
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
FIGS
ZLAB
Price
$12.41
$18.52
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$15.93
$49.60
AVG Volume (30 Days)
4.0M
631.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
850.00
38.46
EPS
0.03
N/A
Revenue
$419,591,000.00
$460,156,000.00
Revenue This Year
$14.09
$9.75
Revenue Next Year
$7.72
$26.03
P/E Ratio
$414.83
N/A
Revenue Growth
59.47
15.33
52 Week Low
$4.25
$15.96
52 Week High
$17.48
$44.34

Technical Indicators

Market Signals
Indicator
FIGS
ZLAB
Relative Strength Index (RSI) 42.96 40.09
Support Level $10.76 $18.29
Resistance Level $15.83 $19.64
Average True Range (ATR) 0.71 1.02
MACD -0.06 -0.22
Stochastic Oscillator 33.61 14.60

Price Performance

Historical Comparison
FIGS
ZLAB

About FIGS FIGS Inc.

FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: